NCT05165316View on ClinicalTrials.gov

European Long-acting Antipsychotics in Schizophrenia Trial-II

Enrolling by invitationOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Schizophrenia
Trial Locations (1)

Unknown

Tel Hashomer The Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Rene Kahn

OTHER